Moncayo A , Yanine MIO , 2006. An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 100: 663–677.
Teixeira ARL , Nitz N , Guimaro MC , Gomes C , Santos-Buch CA , 2006. Chagas disease. Postgrad Med J 82: 788–798.
World Health Organization , 2010. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 90: 33–43.
Global Burden of Disease Collaborative Network , 2020. Global Burden of Disease Study 2019 (GBD 2019) results. Seattle, WA: Institute for Health Metrics and Evaluation; 2020. Available at: http://ghdx.healthdata.org/gbd-results-tool.
Petana WB , 1971. American trypanosomiasis in British Honduras. X. Natural habitats and ecology of Triatoma dimidiata (Hemiptera, Reduviidae) in the El Cayo and Toledo districts, and the prevalence of infection with Trypanosoma (Schizotrypanum) cruzi in the wild-caught bugs. Ann Trop Med Parasitol 65: 169–178.
Ly AN et al.2022. Epidemiological and clinical characteristics of acute dengue virus infections detected through acute febrile illness surveillance, Belize 2020. Viruses 14: 768.
Moser DR , Kirchhoff LV , Donelson JE , 1989. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol 27: 1477–1482.
Souto RP , Fernandes O , Macedo AM , Campbell DA , Zingales B , 1996. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 83: 141–152.
Majeau A , Herrera C , Dumonteil E , 2019. An improved approach to Trypanosoma cruzi molecular genotyping by next-generation sequencing of the mini-exon gene. Methods Mol Biol 1955: 47–60.
Villanueva-Lizama L , Teh-Poot C , Majeau A , Herrera C , Dumonteil E , 2019. Molecular genotyping of Trypanosoma cruzi by next-generation sequencing of the mini-exon gene reveals infections with multiple parasite discrete typing units in Chagasic patients from Yucatan, Mexico. J Infect Dis 219: 1980–1988.
Garrison EMG , 2012. Haplotype-based variant detection from short-read sequencing. arXiv:1207.3907 [q-bio.GN].
Dereeper A et al., 2008. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 36: W465–469.
Polonio R , López-Domínguez J , Herrera C , Dumonteil E , 2021. Molecular ecology of Triatoma dimidiata in southern Belize reveals risk for human infection and the local differentiation of Trypanosoma cruzi parasites. Int J Infect Dis 108: 320–329.
Jaramillo R , Bryan JP , Schur J , Pan AA , 1997. Prevalence of antibody to Trypanosoma cruzi in three populations in Belize. Am J Trop Med Hyg 57: 298–301.
Polonio R , Ramirez-Sierra MJ , Dumonteil E , 2009. Dynamics and distribution of house infestation by Triatoma dimidiata in central and southern Belize. Vector Borne Zoonotic Dis 9: 19–24.
Stevens L , Monroy MC , Rodas AG , Dorn PL , 2014. Hunting, swimming, and worshiping: human cultural practices illuminate the blood meal sources of cave dwelling Chagas vectors (Triatoma dimidiata) in Guatemala and Belize. PLoS Negl Trop Dis 8: e3047.
Garcia MN , Burroughs H , Gorchakov R , Gunter SM , Dumonteil E , Murray KO , Herrera CP , 2017. Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA. Infect Genet Evol 49: 151–156.
Pan American Health Organization , 2012. Certification of the Interruption of Vectoral Transmission of Trypanosoma cruzi in Belize. Available at: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=8791:2013-certificationinterruption-vectoral-transmission-trypanosoma-cruzi-belize&Itemid=40282&lang=en. Accessed February 2, 2022.
de Arias AR , Monroy C , Guhl F , Sosa-Estani S , Santos WS , Abad-Franch F , 2022. Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission. Mem Inst Oswaldo Cruz 117: e210130.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 4078 | 4078 | 755 |
Full Text Views | 48 | 48 | 11 |
PDF Downloads | 55 | 55 | 11 |
In January 2020, we instituted acute febrile illness surveillance in 11 hospitals and clinics across Belize. Within 3 months, we diagnosed an acute case of Chagas disease by polymerase chain reaction in a 7-year-old child in the northern part of the country. Phylogenetic analyses of the parasite from the acute blood specimen revealed a multiclonal Trypanosoma cruzi infection, including parasites from the TcII (25.0% of haplotypes), TcIV (2.5% of haplotypes), and TcV (72.5% of haplotypes) discrete typing units. The family reported no history of travel, and three Triatoma species vectors were found within the home. The child’s mother was seronegative for antibodies to T. cruzi, ruling out congenital transmission. Convalescent blood samples documented seroconversion and confirmed acute infection. The child was successfully treated with nifurtimox. This is the first known diagnosed case of acute Chagas infection in Belize, highlighting the need for further investigation and public health prevention measures.
Financial support: This study was generously funded, in part, by CDC U01 GH002235 (to K. O. M.). The genotyping and genomic analysis was funded in part by the Tulane ByWater Institute–Faculty Fellowships in Interdisciplinary Collaboration 2020 to C. P. H.
Disclaimer: The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the U.S. Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services.
Authors’ addresses: Kristy O. Murray, Sarah M. Gunter, and Shannon E. Ronca, Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; William T. Shearer Center for Human Immunobiology, Texas Children’s Hospital, Houston, Texas; and National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, E-mails: kmurray@bcm.edu, sm22@bcm.edu, and shannon.ronca@bcm.edu. Miguel A. Saldaña, Allison Lino, and Ella Hawes, Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, and William T. Shearer Center for Human Immunobiology, Texas Children’s Hospital, Houston, Texas, E-mails: Miguel.Saldana@phs.hctx.net, Allison.lino@bcm.edu, and ella.hawes@bcm.edu. Russell Manzanero, Kim Bautista, and Francis Morey, Belize Ministry of Health and Wellness, Belmopan, Belize, E-mails: rmanzanero@health.gov.bz, kbautista@health.gov.bz, and fmorey@health.gov.bz. Emily Zielinski-Gutierrez, Rafael Chacon Fuentes, and Beatriz Lopez, U.S. Centers for Disease Control and Prevention—Central America Region, Guatemala City, Guatemala, E-mails: ebz0@cdc.gov, qin8@cdc.gov, and fdx8@cdc.gov. Claudia Herrera and Eric Dumonteil, Department of Tropical Medicine, Vector-Borne and Infectious Disease Research Center, School of Public Health and Tropical Medicine, Tulane University, New Orleans, E-mails: cherrera@tulane.edu and edumonte@tulane.edu. Julie M. Thompson, Department of Tropical Medicine, Vector-Borne and Infectious Disease Research Center, School of Public Health and Tropical Medicine, and Department of Biomedical Science, School of Medicine, Tulane University, New Orleans, Louisiana, E-mail: jthompson4@tulane.edu. Adrianna Maliga, Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, E-mail: Adrianna.maliga@bcm.edu. Gerhaldine H. Morazan, Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, and Belize Ministry of Health and Wellness, Belmopan, Belize, E-mail: gerhaldine.morazan@bcm.edu.